Missense	B-O
variants	B-O
are	B-O
present	B-O
amongst	B-O
the	B-O
healthy	B-O
population,	B-O
but	B-O
some	B-O
of	B-O
them	B-O
are	B-O
causative	B-O
of	B-O
human	B-O
diseases.	B-O
A	B-O
classification	B-O
of	B-O
variants	B-O
associated	B-O
with	B-O
“healthy”	B-O
or	B-O
“diseased”	B-O
states	B-O
is	B-O
therefore	B-O
not	B-O
always	B-O
straightforward.	B-O
A	B-O
deeper	B-O
understanding	B-O
of	B-O
the	B-O
nature	B-O
of	B-O
missense	B-O
variants	B-O
in	B-O
health	B-O
and	B-O
disease,	B-O
the	B-O
cellular	B-O
processes	B-O
they	B-O
may	B-O
affect,	B-O
and	B-O
the	B-O
general	B-O
molecular	B-O
principles	B-O
which	B-O
underlie	B-O
these	B-O
differences	B-O
is	B-O
essential	B-O
to	B-O
offer	B-O
mechanistic	B-O
explanations	B-O
of	B-O
the	B-O
true	B-O
impact	B-O
of	B-O
pathogenic	B-O
variants.	B-O
Here,	B-O
we	B-O
have	B-O
formalised	B-O
a	B-O
statistical	B-O
framework	B-O
which	B-O
enables	B-O
robust	B-O
probabilistic	B-O
quantification	B-O
of	B-O
variant	B-O
enrichment	B-O
across	B-O
full-length	B-O
proteins,	B-O
their	B-O
domains,	B-O
and	B-O
3D	B-O
structure-defined	B-O
regions.	B-O
Using	B-O
this	B-O
framework,	B-O
we	B-O
validate	B-O
and	B-O
extend	B-O
previously	B-O
reported	B-O
trends	B-O
of	B-O
variant	B-O
enrichment	B-O
in	B-O
different	B-O
protein	B-O
structural	B-O
regions	B-O
,	B-O
specific	B-O
constituent	B-O
“domains”	B-O
of	B-O
proteins	B-O
.	B-O
For	B-O
each	B-O
level,	B-O
we	B-O
analyse	B-O
variant	B-O
enrichment	B-O
in	B-O
full-length	B-O
entities	B-O
.	B-O
These	B-O
include	B-O
protein	B-O
structural	B-O
information	B-O
Levels	B-O
of	B-O
the	B-O
protein	B-O
anatomy.	B-O
At	B-O
the	B-O
protein/domain	B-O
level,	B-O
the	B-O
number	B-O
of	B-O
missense	B-O
variants	B-O
in	B-O
a	B-O
protein	B-O
or	B-O
domain	B-O
is	B-O
compared	B-O
to	B-O
the	B-O
number	B-O
of	B-O
missense	B-O
variants	B-O
in	B-O
the	B-O
whole	B-O
dataset	B-O
which	B-O
localise	B-O
to	B-O
defined	B-O
proteins/domains.	B-O
At	B-O
the	B-O
domain-type	B-O
level,	B-O
the	B-O
number	B-O
of	B-O
missense	B-O
variants	B-O
in	B-O
a	B-O
particular	B-O
Pfam	B-O
defined	B-O
domain-type	B-O
is	B-O
compared	B-O
to	B-O
the	B-O
total	B-O
number	B-O
of	B-O
missense	B-O
variants	B-O
which	B-O
localise	B-O
to	B-O
any	B-O
Pfam	B-O
domain-type.	B-O
These	B-O
calculations	B-O
are	B-O
referred	B-O
to	B-O
as	B-O
the	B-O
“full-length”	B-O
protein/domain/domain-type	B-O
variant	B-O
enrichment	B-O
in	B-O
this	B-O
manuscript,	B-O
in	B-O
contrast	B-O
with	B-O
the	B-O
calculations	B-O
at	B-O
regions	B-O
of	B-O
protein	B-O
anatomy	B-O
defined	B-O
next.	B-O
,	B-O
allowing	B-O
for	B-O
intuitive	B-O
interpretation.	B-O
For	B-O
details,	B-O
please	B-O
read	B-O
S1	B-O
Text	B-O
.	B-O
We	B-O
also	B-O
quantified	B-O
the	B-O
robustness	B-O
of	B-O
such	B-O
quantification	B-O
of	B-O
variant	B-O
enrichment:	B-O
The	B-O
significance	B-O
of	B-O
the	B-O
enrichment/depletion	B-O
of	B-O
missense	B-O
variants,	B-O
in	B-O
terms	B-O
of	B-O
their	B-O
density,	B-O
is	B-O
assessed	B-O
by	B-O
comparison	B-O
to	B-O
simulated	B-O
null	B-O
distributions,	B-O
in	B-O
which	B-O
the	B-O
number	B-O
of	B-O
missense	B-O
variants	B-O
is	B-O
kept	B-O
identical	B-O
to	B-O
that	B-O
observed	B-O
in	B-O
the	B-O
data,	B-O
but	B-O
their	B-O
positions	B-O
within	B-O
the	B-O
protein	B-O
are	B-O
randomised.	B-O
This	B-O
goes	B-O
beyond	B-O
similar	B-O
studies	B-O
.	B-O
Some	B-O
proteins	B-O
in	B-O
the	B-O
latter	B-O
group	B-O
also	B-O
show	B-O
enrichment	B-O
in	B-O
interacting	B-O
interfaces,	B-O
but	B-O
a	B-O
clear	B-O
depletion	B-O
of	B-O
mutations	B-O
at	B-O
the	B-O
surface	B-O
is	B-O
evident.	B-O
The	B-O
segregation	B-O
of	B-O
these	B-O
2	B-O
groups	B-O
in	B-O
terms	B-O
of	B-O
cancer	B-O
driver	B-O
status	B-O
has	B-O
strong	B-O
statistical	B-O
support	B-O
.	B-O
This	B-O
reflects	B-O
the	B-O
potential	B-O
disruption,	B-O
caused	B-O
by	B-O
such	B-O
mutations,	B-O
of	B-O
structurally	B-O
and	B-O
functionally	B-O
important	B-O
sites	B-O
[	B-O
20	B-O
,	B-O
21	B-O
,	B-O
25	B-O
].	B-O
The	B-O
enrichment	B-O
of	B-O
ClinVar	B-O
variants	B-O
is	B-O
further	B-O
demonstrated	B-O
by	B-O
their	B-O
tendency	B-O
to	B-O
affect	B-O
residues	B-O
which	B-O
are	B-O
highly	B-O
connected	B-O
when	B-O
considering	B-O
network	B-O
representations	B-O
of	B-O
protein	B-O
structures	B-O
and	B-O
that	B-O
this	B-O
enrichment	B-O
is	B-O
due	B-O
to	B-O
a	B-O
small	B-O
subset	B-O
of	B-O
proteins	B-O
which	B-O
harbour	B-O
a	B-O
large	B-O
number	B-O
of	B-O
variants	B-O
at	B-O
interface	B-O
regions.	B-O
Genes	B-O
in	B-O
which	B-O
these	B-O
variants	B-O
reside	B-O
may	B-O
be	B-O
putative	B-O
driver	B-O
genes	B-O
The	B-O
density	B-O
of	B-O
mutations	B-O
in	B-O
different	B-O
protein	B-O
regions,	B-O
calculated	B-O
using	B-O
Eq	B-O
1	B-O
.	B-O
Density	B-O
values	B-O
.	B-O
ClinVar	B-O
and	B-O
COSMIC	B-O
variants	B-O
are	B-O
depleted	B-O
in	B-O
inter-domain	B-O
disordered	B-O
regions	B-O
and	B-O
enriched	B-O
in	B-O
intra-domain	B-O
ordered	B-O
regions.	B-O
In	B-O
contrast,	B-O
gnomAD	B-O
variants	B-O
,	B-O
ClinVar	B-O
variants	B-O
appear	B-O
enriched	B-O
in	B-O
terms	B-O
of	B-O
the	B-O
density	B-O
of	B-O
missense	B-O
variants	B-O
close	B-O
to	B-O
phosphorylation	B-O
sites	B-O
but	B-O
not	B-O
significantly	B-O
so	B-O
in	B-O
comparison	B-O
to	B-O
the	B-O
simulated	B-O
null	B-O
background;	B-O
this	B-O
may	B-O
be	B-O
again	B-O
due	B-O
to	B-O
data	B-O
sparsity,	B-O
as	B-O
suggested	B-O
by	B-O
large	B-O
bootstrapped	B-O
confidence	B-LF
intervals	B-O
.	B-O
COSMIC	B-O
cancer	B-O
gene	B-O
variants	B-O
are	B-O
also	B-O
close	B-O
to	B-O
phosphorylation	B-O
sites;	B-O
however,	B-O
COSMIC	B-O
noncancer	B-O
gene	B-O
variants,	B-O
which	B-O
appear	B-O
depleted	B-O
in	B-O
terms	B-O
of	B-O
variant	B-O
density,	B-O
are	B-O
also	B-O
significantly	B-O
enriched	B-O
close	B-O
to	B-O
phosphorylation	B-O
sites	B-O
in	B-O
comparison	B-O
to	B-O
simulated	B-O
null	B-O
distributions	B-O
.	B-O
This	B-O
indicates	B-O
that,	B-O
in	B-O
agreement	B-O
with	B-O
a	B-O
number	B-O
of	B-O
other	B-O
studies	B-O
[	B-O
35	B-O
,	B-O
36	B-O
],	B-O
the	B-O
disruption	B-O
of	B-O
phosphorylation	B-O
sites	B-O
may	B-O
play	B-O
a	B-O
particularly	B-O
important	B-O
role	B-O
in	B-O
cancer.	B-O
In	B-O
contrast	B-O
to	B-O
phosphorylation	B-O
sites,	B-O
all	B-O
datasets	B-O
appear	B-O
depleted	B-O
of	B-O
variants	B-O
close	B-O
to	B-O
ubiquitination	B-O
sites	B-O
.	B-O
These	B-O
analyses	B-O
conclude	B-O
that	B-O
the	B-O
enrichment	B-O
of	B-O
missense	B-O
variants	B-O
at	B-O
various	B-O
structural	B-O
features	B-O
consistently	B-O
segregate	B-O
population	B-O
variants	B-O
from	B-O
disease-associated	B-O
ones.	B-O
For	B-O
the	B-O
majority	B-O
of	B-O
structural	B-O
regions	B-O
defined	B-O
here,	B-O
the	B-O
greatest,	B-O
most	B-O
consistent	B-O
distinction	B-O
is	B-O
always	B-O
seen	B-O
between	B-O
common	B-O
and	B-O
ClinVar	B-O
variants,	B-O
provided	B-O
that	B-O
the	B-O
data	B-O
are	B-O
not	B-O
too	B-O
sparse.	B-O
We	B-O
also	B-O
observed	B-O
different	B-O
patterns	B-O
of	B-O
pathway	B-O
enrichment	B-O
for	B-O
variants	B-O
in	B-O
surfaces,	B-O
cores,	B-O
and	B-O
interfaces	B-O
and	B-O
in	B-O
each	B-O
structural	B-O
regions	B-O
are	B-O
depicted.	B-O
Here,	B-O
domain-types	B-O
which	B-O
are	B-O
enriched	B-O
in	B-O
variants	B-O
only	B-O
in	B-O
the	B-O
COSMIC	B-O
and	B-O
ClinVar	B-O
datasets	B-O
can	B-O
be	B-O
seen,	B-O
including	B-O
known	B-O
drug	B-O
targets	B-O
such	B-O
as	B-O
tyrosine	B-O
kinase	B-O
,	B-O
both	B-O
of	B-O
which	B-O
play	B-O
an	B-O
important	B-O
role	B-O
in	B-O
cancer	B-O
[	B-O
39	B-O
,	B-O
40	B-O
].	B-O
Some	B-O
domain-types	B-O
.	B-O
This	B-O
could	B-O
suggest	B-O
that	B-O
these	B-O
domains	B-O
take	B-O
part	B-O
in	B-O
functions	B-O
for	B-O
which	B-O
it	B-O
is	B-O
desirable	B-O
to	B-O
maintain	B-O
diversity	B-O
within	B-O
a	B-O
population;	B-O
however,	B-O
little	B-O
is	B-O
known	B-O
about	B-O
either	B-O
domain-type	B-O
VES	B-AC
at	B-O
the	B-O
full-length	B-O
domain-type	B-O
level.	B-O
Bubble	B-O
sizes	B-O
are	B-O
scaled	B-O
by	B-O
the	B-O
adjusted	B-O
p	B-O
-value	B-O
of	B-O
the	B-O
VES	B-AC
statistic.	B-O
for	B-O
those	B-O
domain-types	B-O
with	B-O
structural	B-O
coverage.	B-O
The	B-O
majority	B-O
of	B-O
domains	B-O
are	B-O
enriched	B-O
in	B-O
gnomAD	B-O
,	B-O
such	B-O
as	B-O
G	B-LF
protein-coupled	I-LF
receptors	B-O
.	B-O
By	B-O
analysing	B-O
drug	B-O
availability	B-O
together	B-O
with	B-O
variant	B-O
enrichment,	B-O
this	B-O
approach	B-O
allows	B-O
for	B-O
more	B-O
informed	B-O
decisions	B-O
in	B-O
selecting	B-O
new	B-O
therapeutic	B-O
targets.	B-O
For	B-O
example,	B-O
there	B-O
are	B-O
domain-types	B-O
which	B-O
could	B-O
be	B-O
targeted	B-O
by	B-O
few	B-O
or	B-O
no	B-O
drugs	B-O
but	B-O
are	B-O
enriched	B-O
in	B-O
COSMIC	B-O
and/or	B-O
ClinVar	B-O
variants.	B-O
This	B-O
could	B-O
offer	B-O
a	B-O
starting	B-O
point	B-O
to	B-O
prioritise	B-O
drug	B-O
discovery	B-O
efforts	B-O
for	B-O
these	B-O
domain-types.	B-O
For	B-O
domain-types	B-O
already	B-O
targetable	B-O
by	B-O
drugs,	B-O
our	B-O
analysis	B-O
highlights	B-O
domains	B-O
to	B-O
which	B-O
multiple	B-O
disease-associated	B-O
variants	B-O
localise,	B-O
which	B-O
could	B-O
give	B-O
scope	B-O
for	B-O
drug	B-O
repurposing	B-O
or	B-O
redesign	B-O
calculated	B-O
for	B-O
each	B-O
dataset.	B-O
The	B-O
pathway	B-O
enrichment	B-O
scores	B-O
were	B-O
then	B-O
subjected	B-O
to	B-O
clustering	B-O
and	B-O
Principal	B-LF
Component	I-LF
Analysis	I-LF
.	B-O
The	B-O
cluster	B-O
visualised	B-O
in	B-O
orange	B-O
is	B-O
primarily	B-O
composed	B-O
of	B-O
terms	B-O
associated	B-O
with	B-O
cancer,	B-O
growth,	B-O
and	B-O
proliferation,	B-O
whereas	B-O
that	B-O
coloured	B-O
in	B-O
pink	B-O
contains	B-O
pathways	B-O
associated	B-O
with	B-O
splicing,	B-O
transcription,	B-O
translation,	B-O
and	B-O
metabolic	B-O
terms.	B-O
Pathways	B-O
associated	B-O
with	B-O
sensory	B-O
perception	B-O
and	B-O
the	B-O
immune	B-O
response	B-O
are	B-O
found	B-O
in	B-O
the	B-O
“green”	B-O
cluster.	B-O
A	B-O
handful	B-O
of	B-O
metabolic	B-O
pathways	B-O
also	B-O
localise	B-O
to	B-O
this	B-O
cluster;	B-O
however,	B-O
these	B-O
appear	B-O
to	B-O
be	B-O
more	B-O
associated	B-O
with	B-O
environmental	B-O
response	B-O
and	B-O
adaptation	B-O
than	B-O
those	B-O
pathways	B-O
found	B-O
in	B-O
the	B-O
“pink”	B-O
cluster;	B-O
for	B-O
example,	B-O
pathways	B-O
associated	B-O
with	B-O
the	B-O
metabolism	B-O
of	B-O
drugs	B-O
and	B-O
xenobiotics	B-O
are	B-O
found	B-O
here.	B-O
For	B-O
brevity,	B-O
the	B-O
“orange,”	B-O
“pink,”	B-O
and	B-O
“green”	B-O
clusters	B-O
will	B-O
be	B-O
termed	B-O
the	B-O
“proliferation,”	B-O
“nucleotide	B-O
processing,”	B-O
and	B-O
“response”	B-O
clusters,	B-O
respectively,	B-O
for	B-O
the	B-O
remainder	B-O
of	B-O
this	B-O
text.	B-O
A	B-O
list	B-O
of	B-O
pathways	B-O
assigned	B-O
to	B-O
each	B-O
cluster	B-O
is	B-O
given	B-O
in	B-O
S7	B-O
Data	B-O
.	B-O
Download:	B-O
PPT	B-O
PowerPoint	B-O
slide	B-O
PNG	B-O
larger	B-O
image	B-O
TIFF	B-O
original	B-O
image	B-O
Fig	B-O
4.	B-O
Pathway	B-O
clusters	B-O
defined	B-O
according	B-O
to	B-O
protein-wise	B-O
variant	B-O
enrichment.	B-O
Pathway	B-O
terms	B-O
visualised	B-O
for	B-O
the	B-O
“proliferation”	B-O
.	B-O
Additionally,	B-O
COSMIC	B-O
variants	B-O
are	B-O
separated	B-O
from	B-O
ClinVar	B-O
variants	B-O
along	B-O
the	B-O
third	B-O
principal	B-O
component	B-O
.	B-O
Closer	B-O
inspection	B-O
of	B-O
the	B-O
pathway	B-O
enrichment	B-O
data	B-O
for	B-O
the	B-O
top	B-O
.	B-O
“Response”	B-O
pathways	B-O
appear	B-O
to	B-O
be	B-O
enriched	B-O
in	B-O
variants	B-O
in	B-O
all	B-O
4	B-O
datasets,	B-O
while	B-O
“proliferation”	B-O
pathways	B-O
are	B-O
consistently	B-O
enriched	B-O
in	B-O
COSMIC	B-O
variants	B-O
alongside	B-O
enrichment	B-O
in	B-O
ClinVar	B-O
variants	B-O
in	B-O
a	B-O
subset	B-O
of	B-O
these	B-O
pathways.	B-O
Enrichment	B-O
in	B-O
ClinVar	B-O
variants	B-O
is	B-O
apparent	B-O
for	B-O
specific	B-O
“nucleotide	B-O
processing”	B-O
functions,	B-O
e.g.,	B-O
ribosomes.	B-O
Proteomics	B-O
and	B-O
transcriptomics	B-O
features	B-O
are	B-O
associated	B-O
with	B-O
variant	B-O
localisation	B-O
Proteins,	B-O
of	B-O
course,	B-O
do	B-O
not	B-O
function	B-O
in	B-O
isolation	B-O
but	B-O
in	B-O
the	B-O
crowded	B-O
environment	B-O
of	B-O
the	B-O
cell	B-O
.	B-O
Therefore,	B-O
the	B-O
properties	B-O
of	B-O
proteins	B-O
in	B-O
cells,	B-O
including	B-O
their	B-O
quantities,	B-O
turnover	B-O
rates,	B-O
and	B-O
thermal	B-O
stability,	B-O
can	B-O
crucially	B-O
affect	B-O
the	B-O
fitness	B-O
of	B-O
a	B-O
protein	B-O
to	B-O
perform	B-O
its	B-O
function.	B-O
Here,	B-O
we	B-O
ask	B-O
if	B-O
variant	B-O
enrichments	B-O
are	B-O
associated	B-O
with	B-O
these	B-O
proteomics	B-O
features.	B-O
We	B-O
have	B-O
made	B-O
use	B-O
of	B-O
large-scale	B-O
proteomics	B-O
data,	B-O
including	B-O
protein	B-O
abundance	B-O
data	B-O
for	B-O
various	B-O
organs	B-O
from	B-O
PaxDb	B-O
,	B-O
proteomics	B-O
surveys	B-O
of	B-O
protein	B-O
half-lives	B-O
and	B-O
thermal	B-O
stability	B-O
[	B-O
14	B-O
,	B-O
15	B-O
],	B-O
together	B-O
with	B-O
transcriptomics	B-O
data	B-O
.	B-O
Extending	B-O
to	B-O
the	B-O
entire	B-O
proteome,	B-O
the	B-O
protein-wise	B-O
VES	B-AC
of	B-O
disease-associated	B-O
variants	B-O
displays	B-O
positive	B-O
correlations	B-O
with	B-O
protein	B-O
abundance,	B-O
expression,	B-O
half-life,	B-O
and	B-O
thermal	B-O
stability,	B-O
whereas	B-O
population	B-O
variants	B-O
exhibit	B-O
the	B-O
opposite	B-O
trend	B-O
.	B-O
However,	B-O
zooming	B-O
into	B-O
the	B-O
enrichment	B-O
of	B-O
variants	B-O
in	B-O
the	B-O
core	B-O
of	B-O
protein	B-O
structures,	B-O
we	B-O
found	B-O
that	B-O
in	B-O
comparison	B-O
to	B-O
all	B-O
regions	B-O
of	B-O
proteins	B-O
with	B-O
resolved	B-O
structure,	B-O
proteins	B-O
more	B-O
enriched	B-O
in	B-O
ClinVar	B-O
variants	B-O
in	B-O
the	B-O
core	B-O
tend	B-O
to	B-O
be	B-O
less	B-O
abundant	B-O
and	B-O
less	B-O
stable,	B-O
whereas	B-O
the	B-O
contrary	B-O
is	B-O
true	B-O
for	B-O
rare	B-O
population	B-O
variants	B-O
.	B-O
Thus,	B-O
our	B-O
results	B-O
indicate	B-O
2	B-O
competing	B-O
trends	B-O
for	B-O
disease-associated	B-O
variants:	B-O
.	B-O
Analogous	B-O
correlations	B-O
for	B-O
variant	B-O
enrichments	B-O
at	B-O
protein	B-O
surfaces	B-O
display	B-O
opposite	B-O
trends	B-O
to	B-O
those	B-O
observed	B-O
at	B-O
the	B-O
protein	B-O
cores	B-O
.	B-O
Due	B-O
to	B-O
the	B-O
relative	B-O
sparsity	B-O
of	B-O
variants	B-O
which	B-O
map	B-O
to	B-O
protein	B-O
interfaces,	B-O
we	B-O
believe	B-O
it	B-O
is	B-O
difficult	B-O
to	B-O
draw	B-O
robust	B-O
conclusions	B-O
from	B-O
any	B-O
trends	B-O
observed	B-O
for	B-O
correlations	B-O
of	B-O
proteomics	B-O
data	B-O
with	B-O
variant	B-O
enrichment	B-O
at	B-O
protein–protein	B-O
interaction	B-O
sites.	B-O
Download:	B-O
PPT	B-O
PowerPoint	B-O
slide	B-O
PNG	B-O
larger	B-O
image	B-O
TIFF	B-O
original	B-O
image	B-O
Fig	B-O
5.	B-O
The	B-O
protein-wise	B-O
enrichment	B-O
of	B-O
missense	B-O
variants	B-O
in	B-O
comparison	B-O
to	B-O
protein	B-O
abundance,	B-O
expression,	B-O
and	B-O
stability.	B-O
Spearman	B-O
correlations	B-O
for	B-O
missense	B-O
variant	B-O
enrichment	B-O
Functional	B-O
enrichment	B-O
of	B-O
proteins	B-O
in	B-O
KEGG	B-O
pathways	B-O
according	B-O
to	B-O
Tm.	B-O
The	B-O
NES	B-O
for	B-O
each	B-O
pathway	B-O
is	B-O
shown	B-O
on	B-O
the	B-O
vertical	B-O
axis.	B-O
KEGG	B-O
pathways	B-O
are	B-O
listed	B-O
on	B-O
the	B-O
horizontal	B-O
axis	B-O
and	B-O
grouped	B-O
to	B-O
the	B-O
3	B-O
clusters	B-O
as	B-O
defined	B-O
in	B-O
Fig	B-O
4	B-O
.	B-O
See	B-O
S11	B-O
Fig	B-O
for	B-O
a	B-O
complete	B-O
list	B-O
of	B-O
pathways	B-O
depicted	B-O
here.	B-O
S10	B-O
Data	B-O
contains	B-O
the	B-O
underlying	B-O
data.	B-O
KEGG,	B-O
Kyoto	B-O
Encyclopedia	B-O
of	B-O
Genes	B-O
and	B-O
Genomes;	B-O
NES,	B-O
Normalised	B-O
Enrichment	B-O
Score;	B-O
Tm,	B-O
melting	B-O
temperature;	B-O
VES,	B-O
Variant	B-O
Enrichment	B-O
Score.	B-O
We	B-O
highlight	B-O
two	B-O
more	B-O
observations	B-O
in	B-O
terms	B-O
of	B-O
the	B-O
interplay	B-O
between	B-O
proteomics	B-O
features.	B-O
First,	B-O
the	B-O
various	B-O
proteomics	B-O
features	B-O
examined	B-O
here	B-O
are	B-O
interdependent.	B-O
Protein	B-O
abundance	B-O
and	B-O
thermal	B-O
stability	B-O
are	B-O
significantly	B-O
correlated	B-O
with	B-O
one	B-O
another	B-O
,	B-O
albeit	B-O
with	B-O
a	B-O
low	B-O
correlation	B-O
coefficient.	B-O
The	B-O
correlation	B-O
values	B-O
displayed	B-O
in	B-O
Fig	B-O
5	B-O
are	B-O
also	B-O
typically	B-O
of	B-O
a	B-O
weak	B-O
effect.	B-O
Therefore,	B-O
the	B-O
interplay	B-O
between	B-O
variant	B-O
enrichment	B-O
and	B-O
proteomics	B-O
features	B-O
appear	B-O
multifaceted	B-O
and	B-O
complex.	B-O
Secondly,	B-O
in	B-O
the	B-O
analysis	B-O
of	B-O
protein	B-O
abundance,	B-O
the	B-O
trends	B-O
observed	B-O
with	B-O
variant	B-O
enrichment	B-O
at	B-O
both	B-O
full-length	B-O
proteins	B-O
and	B-O
specifically	B-O
the	B-O
protein	B-O
core	B-O
are	B-O
less	B-O
pronounced	B-O
for	B-O
cell	B-O
line	B-O
data	B-O
and	B-O
break	B-O
down	B-O
for	B-O
extracellular	B-O
fluids	B-O
.	B-O
The	B-O
correlation	B-O
is	B-O
most	B-O
evident	B-O
for	B-O
tissues	B-O
containing	B-O
long-lived	B-O
cell-types,	B-O
such	B-O
as	B-O
the	B-O
brain,	B-O
ovary,	B-O
and	B-O
testis.	B-O
Transcriptomics	B-O
data	B-O
again	B-O
reinforce	B-O
this	B-O
picture,	B-O
albeit	B-O
with	B-O
less	B-O
contrast	B-O
between	B-O
datasets	B-O
.	B-O
An	B-O
exception	B-O
to	B-O
this	B-O
is	B-O
protein	B-O
thermal	B-O
stability:	B-O
Pathways	B-O
which	B-O
belong	B-O
to	B-O
the	B-O
“proliferation”	B-O
cluster	B-O
are	B-O
clearly	B-O
enriched	B-O
in	B-O
proteins	B-O
of	B-O
lower	B-O
stability	B-O
than	B-O
the	B-O
other	B-O
2	B-O
clusters	B-O
.	B-O
This	B-O
suggests	B-O
that	B-O
proliferation-related	B-O
proteins	B-O
may	B-O
be	B-O
vulnerable	B-O
to	B-O
disruption	B-O
by	B-O
mutations	B-O
which	B-O
localise	B-O
to	B-O
their	B-O
already	B-O
unstable	B-O
cores.	B-O
Taken	B-O
together,	B-O
these	B-O
analyses	B-O
provide	B-O
fine	B-O
molecular	B-O
details	B-O
into	B-O
defining	B-O
both	B-O
the	B-O
resilience	B-O
towards	B-O
variants,	B-O
and	B-O
the	B-O
sensitivity	B-O
towards	B-O
variants,	B-O
for	B-O
a	B-O
given	B-O
protein	B-O
.	B-O
If	B-O
more	B-O
stringent	B-O
MAF	B-AC
thresholds	B-O
are	B-O
used	B-O
to	B-O
define	B-O
rare	B-O
variants,	B-O
their	B-O
properties	B-O
move	B-O
towards	B-O
those	B-O
of	B-O
disease-associated	B-O
variants	B-O
but	B-O
still	B-O
remain	B-O
closest	B-O
to	B-O
those	B-O
of	B-O
common	B-O
variants	B-O
.	B-O
A	B-O
visible	B-O
separation	B-O
between	B-O
common	B-O
and	B-O
rare	B-O
variants,	B-O
especially	B-O
in	B-O
the	B-O
pathway	B-O
analysis,	B-O
can	B-O
only	B-O
be	B-O
seen	B-O
if	B-O
an	B-O
extreme	B-O
MAF	B-AC
cutoff	B-O
As	B-O
for	B-O
Fig	B-O
4B	B-O
,	B-O
but	B-O
only	B-O
the	B-O
first	B-O
2	B-O
PCs	B-O
are	B-O
depicted,	B-O
and,	B-O
in	B-O
separated	B-O
panels,	B-O
increasingly	B-O
stringent	B-O
MAFs	B-O
used	B-O
to	B-O
define	B-O
rare	B-O
variants.	B-O
MAF	B-AC
cutoffs	B-O
of	B-O
0.01	B-O
,	B-O
0.001	B-O
and	B-O
rank	B-O
them	B-O
by	B-O
2	B-O
in	B-O
silico	B-O
variant	B-O
impact	B-O
predictors,	B-O
REVEL	B-O
and	B-O
CADD	B-O
.	B-O
Based	B-O
on	B-O
the	B-O
scores	B-O
provided	B-O
by	B-O
these	B-O
predictors,	B-O
we	B-O
proceeded	B-O
to	B-O
compare	B-O
“tolerable”	B-O
and	B-O
“damaging”	B-O
variants	B-O
labelled	B-O
by	B-O
these	B-O
predictions	B-O
in	B-O
terms	B-O
of	B-O
the	B-O
features	B-O
we	B-O
discussed	B-O
above.	B-O
The	B-O
majority	B-O
of	B-O
ClinVar	B-O
variants	B-O
were	B-O
classified	B-O
damaging	B-O
,	B-O
whereas	B-O
the	B-O
majority	B-O
of	B-O
COSMIC	B-O
and	B-O
gnomAD	B-O
variants	B-O
were	B-O
deemed	B-O
tolerable.	B-O
Under	B-O
our	B-O
chosen	B-O
cutoff	B-O
.	B-O
We	B-O
found	B-O
that	B-O
damaging	B-O
variants	B-O
are	B-O
enriched	B-O
in	B-O
protein	B-O
cores	B-O
and	B-O
interacting	B-O
interfaces	B-O
while	B-O
depleted	B-O
in	B-O
protein	B-O
surfaces	B-O
,	B-O
similar	B-O
to	B-O
the	B-O
ClinVar	B-O
and	B-O
COSMIC	B-O
variants	B-O
above	B-O
.	B-O
Tolerable	B-O
variants	B-O
show	B-O
the	B-O
opposite	B-O
trends	B-O
which	B-O
resemble	B-O
that	B-O
of	B-O
the	B-O
gnomAD	B-O
variants.	B-O
Similarly,	B-O
protein	B-O
stability	B-O
and	B-O
abundance	B-O
also	B-O
segregate	B-O
tolerable	B-O
from	B-O
damaging	B-O
variants	B-O
in	B-O
the	B-O
same	B-O
way	B-O
for	B-O
ClinVar/COSMIC	B-O
versus	B-O
gnomAD	B-O
variants	B-O
:	B-O
Damaging	B-O
variants	B-O
tend	B-O
to	B-O
localise	B-O
to	B-O
more	B-O
stable	B-O
and	B-O
more	B-O
abundant	B-O
proteins.	B-O
However,	B-O
such	B-O
variants	B-O
are	B-O
more	B-O
likely	B-O
to	B-O
be	B-O
found	B-O
in	B-O
the	B-O
core	B-O
of	B-O
proteins	B-O
which	B-O
are	B-O
less	B-O
stable	B-O
and	B-O
less	B-O
abundant.	B-O
These	B-O
distinctions	B-O
described	B-O
here	B-O
are	B-O
also	B-O
present	B-O
if	B-O
variants	B-O
are	B-O
binned	B-O
using	B-O
CADD	B-O
scores	B-O
.	B-O
These	B-O
data	B-O
indicate	B-O
that	B-O
the	B-O
molecular	B-O
features	B-O
that	B-O
we	B-O
discovered	B-O
via	B-O
comparing	B-O
ClinVar,	B-O
COSMIC,	B-O
and	B-O
gnomAD	B-O
variants	B-O
are	B-O
independent	B-O
from	B-O
such	B-O
crude	B-O
labelling	B-O
based	B-O
on	B-O
the	B-O
databases	B-O
from	B-O
which	B-O
these	B-O
variant	B-O
data	B-O
are	B-O
collected.	B-O
Rather,	B-O
they	B-O
are	B-O
associated	B-O
with	B-O
variant	B-O
impact,	B-O
as	B-O
assessed	B-O
by	B-O
orthogonal	B-O
measures	B-O
independent	B-O
from	B-O
our	B-O
approach.	B-O
Download:	B-O
PPT	B-O
PowerPoint	B-O
slide	B-O
PNG	B-O
larger	B-O
image	B-O
TIFF	B-O
original	B-O
image	B-O
Fig	B-O
7.	B-O
Orthogonal	B-O
variant	B-O
impact	B-O
predictions	B-O
validate	B-O
structural	B-O
and	B-O
proteomics	B-O
features.	B-O
The	B-O
correlation	B-O
between	B-O
VES	B-AC
calculated	B-O
at	B-O
the	B-O
whole-protein	B-O
level	B-O
The	B-O
enrichment	B-O
of	B-O
surface,	B-O
core,	B-O
and	B-O
interacting	B-O
interface	B-O
over	B-O
variants	B-O
ranked	B-O
by	B-O
REVEL	B-O
score.	B-O
The	B-O
enrichment	B-O
score	B-O
from	B-O
the	B-O
GSEA	B-AC
procedure	B-O
was	B-O
plotted	B-O
here.	B-O
The	B-O
absence	B-O
of	B-O
enrichment	B-O
would	B-O
result	B-O
in	B-O
a	B-O
flat	B-O
line	B-O
at	B-O
0	B-O
.	B-O
This	B-O
further	B-O
demonstrates	B-O
the	B-O
validity	B-O
of	B-O
structural	B-O
localisation	B-O
as	B-O
a	B-O
reliable	B-O
feature	B-O
to	B-O
distinguish	B-O
between	B-O
tolerable	B-O
and	B-O
damaging	B-O
variants.	B-O
Finally,	B-O
tolerable	B-O
and	B-O
damaging	B-O
variants	B-O
are	B-O
also	B-O
enriched	B-O
indistinct	B-O
functional	B-O
pathways	B-O
.	B-O
Some	B-O
“response”	B-O
pathways	B-O
tend	B-O
to	B-O
be	B-O
associated	B-O
with	B-O
tolerable	B-O
variants,	B-O
while	B-O
“proliferation”	B-O
and	B-O
“nucleotide	B-O
processing”	B-O
pathways	B-O
are	B-O
more	B-O
associated	B-O
with	B-O
damaging	B-O
variants,	B-O
analogous	B-O
to	B-O
the	B-O
analysis	B-O
on	B-O
disparate	B-O
variant	B-O
sets	B-O
as	B-O
we	B-O
see	B-O
previously	B-O
in	B-O
Fig	B-O
4	B-O
.	B-O
Taken	B-O
together,	B-O
using	B-O
orthogonal	B-O
variant	B-O
impact	B-O
predictors,	B-O
we	B-O
validate	B-O
that	B-O
structural	B-O
and	B-O
proteomics	B-O
features	B-O
do	B-O
indeed	B-O
hold	B-O
segregating	B-O
power	B-O
for	B-O
tolerable	B-O
and	B-O
damaging	B-O
variants.	B-O
This	B-O
suggests	B-O
the	B-O
use	B-O
of	B-O
the	B-O
features	B-O
discovered	B-O
in	B-O
our	B-O
analyses	B-O
above	B-O
as	B-O
a	B-O
promising	B-O
avenue	B-O
to	B-O
construct	B-O
next-generation	B-O
variant	B-O
impact	B-O
predictors	B-O
.	B-O
Additionally,	B-O
we	B-O
find	B-O
that	B-O
the	B-O
properties	B-O
of	B-O
rare	B-O
variants	B-O
remain	B-O
close	B-O
to	B-O
those	B-O
of	B-O
common	B-O
variants.	B-O
These	B-O
findings	B-O
contrast	B-O
with	B-O
other	B-O
observations	B-O
which	B-O
suggest	B-O
that	B-O
common	B-O
variants	B-O
have	B-O
more	B-O
impact	B-O
on	B-O
molecular	B-O
function	B-O
than	B-O
rare	B-O
variants.	B-O
In	B-O
this	B-O
study,	B-O
only	B-O
for	B-O
a	B-O
few	B-O
proteomics	B-O
properties,	B-O
such	B-O
as	B-O
the	B-O
thermal	B-O
stability	B-O
and	B-O
abundance	B-O
of	B-O
the	B-O
affected	B-O
proteins,	B-O
common	B-O
variants	B-O
appear	B-O
closer	B-O
in	B-O
character	B-O
to	B-O
disease-associated	B-O
variants	B-O
than	B-O
to	B-O
rare	B-O
variants.	B-O
However,	B-O
for	B-O
these	B-O
few	B-O
properties,	B-O
the	B-O
results	B-O
might	B-O
not	B-O
be	B-O
robust	B-O
due	B-O
to	B-O
sparsity	B-O
of	B-O
the	B-O
data.	B-O
Rare	B-O
genetic	B-O
variations	B-O
are	B-O
abundant	B-O
across	B-O
individuals	B-O
[	B-O
51	B-O
,	B-O
52	B-O
],	B-O
with	B-O
some	B-O
predicted	B-O
to	B-O
confer	B-O
a	B-O
regulatory	B-O
impact	B-O
or	B-O
loss	B-O
of	B-O
function	B-O
.	B-O
Alhuzimi	B-O
and	B-O
colleagues	B-O
suggest	B-O
that	B-O
the	B-O
properties	B-O
of	B-O
genes	B-O
enriched	B-O
in	B-O
rare	B-O
population	B-O
variants	B-O
are	B-O
similar	B-O
to	B-O
those	B-O
enriched	B-O
in	B-O
disease-associated	B-O
variants	B-O
and	B-O
are	B-O
thus	B-O
good	B-O
candidates	B-O
for	B-O
discovering	B-O
novel	B-O
disease	B-O
associations.	B-O
Instead,	B-O
we	B-O
show	B-O
that	B-O
proteins	B-O
enriched	B-O
in	B-O
rare	B-O
variants	B-O
are,	B-O
based	B-O
on	B-O
the	B-O
associated	B-O
functional	B-O
pathways,	B-O
most	B-O
similar	B-O
to	B-O
those	B-O
enriched	B-O
in	B-O
common	B-O
variants	B-O
.	B-O
Moreover,	B-O
our	B-O
results	B-O
show	B-O
that	B-O
population	B-O
variants	B-O
implicate	B-O
functions	B-O
mainly	B-O
associated	B-O
with	B-O
environmental	B-O
response	B-O
,	B-O
in	B-O
agreement	B-O
with	B-O
results	B-O
from	B-O
evolutionary	B-O
studies	B-O
reviewed	B-O
in	B-O
.	B-O
We	B-O
have	B-O
dissected	B-O
the	B-O
extent	B-O
of	B-O
variant	B-O
enrichment	B-O
in	B-O
diverse	B-O
datasets	B-O
and	B-O
across	B-O
different	B-O
protein	B-O
regions	B-O
.	B-O
Whereas	B-O
protein	B-O
structural	B-O
information	B-O
has	B-O
been	B-O
utilised	B-O
to	B-O
annotate	B-O
genetic	B-O
variants	B-O
and	B-O
prioritise	B-O
impactful	B-O
variants	B-O
for	B-O
further	B-O
investigations,	B-O
many	B-O
of	B-O
the	B-O
published	B-O
methods	B-O
focus	B-O
on	B-O
3D-structural	B-O
“hotspots,”	B-O
prioritising	B-O
variants	B-O
which	B-O
cluster	B-O
in	B-O
three-dimensional	B-O
space	B-O
[	B-O
20	B-O
,	B-O
21	B-O
,	B-O
25	B-O
,	B-O
26	B-O
,	B-O
34	B-O
]	B-O
but	B-O
also	B-O
shed	B-O
light	B-O
on	B-O
the	B-O
debate	B-O
as	B-O
to	B-O
whether	B-O
somatic	B-O
cancer	B-O
variants	B-O
are	B-O
enriched	B-O
in	B-O
interface	B-O
regions,	B-O
by	B-O
simulating	B-O
null	B-O
distributions	B-O
of	B-O
variants	B-O
.	B-O
These	B-O
simulations	B-O
show	B-O
that	B-O
it	B-O
is	B-O
essential	B-O
to	B-O
consider	B-O
that	B-O
variants	B-O
from	B-O
different	B-O
datasets	B-O
are	B-O
not	B-O
uniformly	B-O
and	B-O
randomly	B-O
distributed	B-O
throughout	B-O
the	B-O
proteome.	B-O
A	B-O
similar	B-O
simulation-based	B-O
approach	B-O
was	B-O
taken	B-O
by	B-O
Gress	B-O
and	B-O
colleagues	B-O
,	B-O
but	B-O
they	B-O
found	B-O
no	B-O
significant	B-O
enrichment	B-O
for	B-O
COSMIC	B-O
variants	B-O
in	B-O
interface	B-O
regions.	B-O
While	B-O
they	B-O
analysed	B-O
a	B-O
filtered	B-O
set	B-O
of	B-O
mutations	B-O
likely	B-O
to	B-O
play	B-O
a	B-O
driver	B-O
role,	B-O
we	B-O
investigated	B-O
all	B-O
somatic	B-O
variants	B-O
and	B-O
addressed	B-O
separately	B-O
mutations	B-O
that	B-O
localise	B-O
to	B-O
defined	B-O
cancer	B-O
and	B-O
noncancer	B-O
genes.	B-O
Our	B-O
analysis	B-O
has	B-O
of	B-O
course	B-O
been	B-O
limited	B-O
by	B-O
the	B-O
number	B-O
of	B-O
proteins	B-O
with	B-O
available	B-O
structural	B-O
data,	B-O
despite	B-O
enrichment	B-O
with	B-O
homologous	B-O
structures.	B-O
We	B-O
are	B-O
also	B-O
still	B-O
limited	B-O
by	B-O
the	B-O
structural	B-O
coverage	B-O
of	B-O
protein	B-O
interactions;	B-O
although	B-O
enough	B-O
data	B-O
exist	B-O
to	B-O
uncover	B-O
broad	B-O
trends,	B-O
our	B-O
analyses	B-O
of	B-O
protein–protein	B-O
interaction	B-O
sites	B-O
generally	B-O
lacked	B-O
statistical	B-O
power.	B-O
Moreover,	B-O
it	B-O
is	B-O
likely	B-O
that	B-O
a	B-O
more	B-O
detailed	B-O
picture	B-O
will	B-O
emerge	B-O
if	B-O
different	B-O
classes	B-O
of	B-O
protein	B-O
interactions	B-O
.	B-O
Together	B-O
with	B-O
functional	B-O
pathways	B-O
and	B-O
structural	B-O
localisation,	B-O
we	B-O
have	B-O
identified	B-O
a	B-O
set	B-O
of	B-O
features,	B-O
based	B-O
on	B-O
which	B-O
different	B-O
parts	B-O
of	B-O
the	B-O
proteome	B-O
could	B-O
be	B-O
assessed	B-O
for	B-O
their	B-O
tendency	B-O
to	B-O
be	B-O
enriched	B-O
in	B-O
disease-associated	B-O
or	B-O
population	B-O
variants	B-O
.	B-O
Population	B-O
variants	B-O
are	B-O
enriched	B-O
on	B-O
protein	B-O
surfaces	B-O
but	B-O
depleted	B-O
in	B-O
core	B-O
and	B-O
interacting	B-O
sites,	B-O
and	B-O
tend	B-O
to	B-O
be	B-O
found	B-O
in	B-O
less	B-O
abundant,	B-O
less	B-O
stable	B-O
proteins.	B-O
These	B-O
features	B-O
could	B-O
potentially	B-O
contribute	B-O
to	B-O
“resilience”	B-O
towards	B-O
missense	B-O
variants,	B-O
by	B-O
limiting	B-O
the	B-O
impact	B-O
on	B-O
proteins	B-O
harbouring	B-O
such	B-O
variants.	B-O
On	B-O
the	B-O
other	B-O
hand,	B-O
disease-associated	B-O
variants	B-O
localise	B-O
preferentially	B-O
to	B-O
proteins	B-O
which	B-O
are	B-O
highly	B-O
expressed	B-O
and	B-O
abundant	B-O
.	B-O
However,	B-O
when	B-O
selectively	B-O
looking	B-O
at	B-O
variants	B-O
mapping	B-O
to	B-O
protein	B-O
cores,	B-O
which	B-O
presumably	B-O
could	B-O
bring	B-O
about	B-O
the	B-O
most	B-O
dramatic	B-O
impact	B-O
on	B-O
fitness,	B-O
disease-associated	B-O
variants	B-O
are	B-O
actually	B-O
associated	B-O
with	B-O
cores	B-O
of	B-O
less	B-O
stable,	B-O
less	B-O
abundant	B-O
proteins	B-O
.	B-O
Such	B-O
proteins	B-O
are	B-O
conceivably	B-O
easier	B-O
to	B-O
inflict	B-O
damage	B-O
at	B-O
the	B-O
core	B-O
and	B-O
be	B-O
eliminated	B-O
via	B-O
selection;	B-O
these	B-O
lethal	B-O
variants	B-O
suffer	B-O
from	B-O
undersampling	B-O
in	B-O
the	B-O
data	B-O
analysed	B-O
here.	B-O
On	B-O
the	B-O
other	B-O
hand,	B-O
some	B-O
variants	B-O
which	B-O
localise	B-O
to	B-O
sensitive	B-O
proteins	B-O
may	B-O
bring	B-O
benefits	B-O
to	B-O
cell	B-O
viability;	B-O
these	B-O
variants	B-O
could	B-O
ascertain	B-O
a	B-O
role	B-O
in	B-O
driving	B-O
cancers.	B-O
Download:	B-O
PPT	B-O
PowerPoint	B-O
slide	B-O
PNG	B-O
larger	B-O
image	B-O
TIFF	B-O
original	B-O
image	B-O
Fig	B-O
8.	B-O
Summary	B-O
of	B-O
analyses.	B-O
Here,	B-O
we	B-O
have	B-O
explored	B-O
patterns	B-O
of	B-O
structural	B-O
localisation,	B-O
abundance,	B-O
and	B-O
stability	B-O
for	B-O
proteins	B-O
enriched	B-O
in	B-O
disease-associated	B-O
and	B-O
population	B-O
variants	B-O
respectively.	B-O
These	B-O
molecular	B-O
attributes	B-O
determine	B-O
the	B-O
resilience	B-O
and	B-O
sensitivity	B-O
of	B-O
the	B-O
proteins	B-O
towards	B-O
missense	B-O
variants	B-O
.	B-O
Here,	B-O
by	B-O
annotating	B-O
structural	B-O
and	B-O
proteomics	B-O
features	B-O
to	B-O
the	B-O
proteins	B-O
harbouring	B-O
variants,	B-O
we	B-O
offer	B-O
explanations	B-O
of	B-O
the	B-O
possible	B-O
mechanisms	B-O
through	B-O
which	B-O
a	B-O
variant	B-O
might	B-O
confer	B-O
its	B-O
impact,	B-O
enriching	B-O
information	B-O
provided	B-O
by	B-O
variant	B-O
impact	B-O
scores	B-O
which	B-O
appears	B-O
intuitive	B-O
yet	B-O
could	B-O
imply	B-O
vastly	B-O
different	B-O
molecular	B-O
underpinnings	B-O
.	B-O
The	B-O
detailed	B-O
set	B-O
of	B-O
protein	B-O
features	B-O
we	B-O
provide	B-O
could	B-O
also	B-O
be	B-O
harnessed	B-O
for	B-O
more	B-O
systematic	B-O
improvement	B-O
of	B-O
variant	B-O
impact	B-O
interpretation.	B-O
Firstly,	B-O
the	B-O
analysis	B-O
concerning	B-O
protein	B-O
stability	B-O
suggests	B-O
it	B-O
is	B-O
important	B-O
to	B-O
consider	B-O
the	B-O
baseline	B-O
stability	B-O
of	B-O
the	B-O
protein	B-O
in	B-O
question	B-O
when	B-O
assessing	B-O
the	B-O
impact	B-O
a	B-O
variant	B-O
could	B-O
bring.	B-O
A	B-O
number	B-O
of	B-O
algorithms	B-O
have	B-O
used	B-O
the	B-O
estimated	B-O
change	B-O
in	B-O
protein	B-O
stability	B-O
upon	B-O
mutation	B-O
,	B-O
which	B-O
lends	B-O
support	B-O
to	B-O
these	B-O
conclusions.	B-O
However,	B-O
we	B-O
also	B-O
point	B-O
out,	B-O
by	B-O
considering	B-O
variants	B-O
at	B-O
the	B-O
protein	B-O
core,	B-O
that	B-O
a	B-O
mutation	B-O
in	B-O
an	B-O
already	B-O
unstable	B-O
protein	B-O
is	B-O
more	B-O
likely	B-O
to	B-O
result	B-O
in	B-O
complete/partial	B-O
unfolding	B-O
under	B-O
physiological	B-O
conditions.	B-O
This	B-O
is	B-O
likely	B-O
to	B-O
be	B-O
relevant	B-O
to	B-O
globular	B-O
proteins,	B-O
whereas	B-O
for	B-O
other	B-O
types	B-O
of	B-O
proteins,	B-O
e.g.,	B-O
intrinsically	B-O
disordered	B-O
proteins,	B-O
function	B-O
will	B-O
be	B-O
related	B-O
less	B-O
to	B-O
the	B-O
fold	B-O
and	B-O
the	B-O
density	B-O
of	B-O
the	B-O
protein	B-O
core.	B-O
These	B-O
factors	B-O
should	B-O
be	B-O
brought	B-O
into	B-O
consideration	B-O
when	B-O
interpreting	B-O
the	B-O
impact	B-O
of	B-O
missense	B-O
variants.	B-O
Secondly,	B-O
we	B-O
show	B-O
that	B-O
the	B-O
combination	B-O
of	B-O
protein	B-O
structures,	B-O
functional	B-O
pathways,	B-O
and	B-O
proteomics	B-O
measurements	B-O
has	B-O
the	B-O
potential	B-O
to	B-O
offer	B-O
valuable	B-O
mechanistic	B-O
insights	B-O
into	B-O
the	B-O
properties	B-O
of	B-O
variants.	B-O
For	B-O
example,	B-O
it	B-O
can	B-O
be	B-O
clearly	B-O
seen	B-O
that	B-O
population	B-O
variants	B-O
are	B-O
most	B-O
enriched	B-O
on	B-O
protein	B-O
surface	B-O
and	B-O
take	B-O
part	B-O
in	B-O
pathways	B-O
belonging	B-O
to	B-O
the	B-O
“proliferation”	B-O
cluster	B-O
.	B-O
Such	B-O
pathways	B-O
also	B-O
appear	B-O
to	B-O
be	B-O
enriched	B-O
in	B-O
proteins	B-O
with	B-O
less	B-O
thermal	B-O
stability	B-O
,	B-O
suggesting	B-O
a	B-O
possible	B-O
mechanistic	B-O
basis	B-O
underlying	B-O
the	B-O
localisation	B-O
of	B-O
variants	B-O
of	B-O
variant	B-O
enrichment	B-O
with	B-O
proteomics	B-O
features	B-O
complements	B-O
a	B-O
body	B-O
of	B-O
research	B-O
which	B-O
concludes	B-O
that	B-O
the	B-O
rate	B-O
of	B-O
protein	B-O
evolution	B-O
correlates	B-O
negatively	B-O
with	B-O
protein	B-O
expression	B-O
and	B-O
abundance	B-O
,	B-O
the	B-O
extent	B-O
of	B-O
which	B-O
has	B-O
been	B-O
found	B-O
to	B-O
be	B-O
tissue	B-O
specific;	B-O
those	B-O
tissues	B-O
with	B-O
a	B-O
high	B-O
neuron	B-O
density	B-O
demonstrating	B-O
the	B-O
highest	B-O
anticorrelation	B-O
.	B-O
Consistent	B-O
with	B-O
this,	B-O
we	B-O
found	B-O
the	B-O
largest	B-O
negative	B-O
correlation	B-O
for	B-O
the	B-O
protein-wise	B-O
enrichment	B-O
of	B-O
rare	B-O
variants,	B-O
from	B-O
the	B-O
gnomAD	B-O
dataset,	B-O
with	B-O
protein	B-O
abundance	B-O
in	B-O
the	B-O
brain	B-O
and,	B-O
interestingly,	B-O
also	B-O
in	B-O
the	B-O
ovary	B-O
and	B-O
testis,	B-O
which	B-O
both	B-O
harbour	B-O
long-lived	B-O
germline	B-O
progenitor	B-O
cells	B-O
.	B-O
Purportedly,	B-O
the	B-O
life	B-O
span	B-O
of	B-O
long-lived	B-O
cells	B-O
renders	B-O
them	B-O
more	B-O
sensitive	B-O
to	B-O
,	B-O
which	B-O
includes	B-O
the	B-O
mapping	B-O
of	B-O
targeted	B-O
drugs,	B-O
besides	B-O
providing	B-O
another	B-O
feature	B-O
for	B-O
the	B-O
characterisation	B-O
of	B-O
variants,	B-O
will	B-O
allow	B-O
for	B-O
more	B-O
informed	B-O
decisions	B-O
in	B-O
optimising	B-O
therapeutic	B-O
strategies.	B-O
For	B-O
example,	B-O
targets	B-O
with	B-O
few	B-O
population	B-O
variants	B-O
could	B-O
be	B-O
selected,	B-O
to	B-O
minimise	B-O
differential	B-O
drug	B-O
response	B-O
due	B-O
to	B-O
genetic	B-O
differences	B-O
between	B-O
individuals.	B-O
Interestingly,	B-O
it	B-O
has	B-O
recently	B-O
been	B-O
shown	B-O
that	B-O
genetic	B-O
variants	B-O
in	B-O
such	B-O
domains	B-O
.	B-O
We	B-O
first	B-O
define	B-O
a	B-O
list	B-O
of	B-O
“levels”	B-O
of	B-O
the	B-O
anatomy,	B-O
namely:	B-O
The	B-O
number	B-O
of	B-O
missense	B-O
variants	B-O
is	B-O
modelled	B-O
as	B-O
a	B-O
binomial	B-O
variable.	B-O
The	B-O
cumulative	B-O
distributive	B-O
function	B-O
of	B-O
this	B-O
binomial	B-O
variable	B-O
is	B-O
taken	B-O
as	B-O
a	B-O
VES	B-AC
for	B-O
the	B-O
level	B-O
examined.	B-O
was	B-O
used	B-O
to	B-O
assess	B-O
the	B-O
missense	B-O
variant	B-O
enrichment	B-O
of	B-O
a	B-O
given	B-O
entity	B-O
,	B-O
and	B-O
the	B-O
two-tailed	B-O
binomial	B-O
test	B-O
was	B-O
used	B-O
to	B-O
assess	B-O
the	B-O
significance	B-O
of	B-O
enrichment/depletion.	B-O
≤	B-O
k	B-O
)	B-O
is	B-O
the	B-O
cumulative	B-O
probability	B-O
of	B-O
observing	B-O
k	B-O
missense	B-O
variants	B-O
in	B-O
the	B-O
chosen	B-O
entity.	B-O
We	B-O
took	B-O
the	B-O
approach	B-O
used	B-O
in	B-O
to	B-O
identify	B-O
protein	B-O
interfaces	B-O
enriched	B-O
in	B-O
cancer	B-O
variants	B-O
and	B-O
generalised	B-O
this	B-O
to	B-O
look	B-O
not	B-O
only	B-O
at	B-O
interfaces	B-O
but	B-O
other	B-O
regions	B-O
and	B-O
levels	B-O
defined	B-O
in	B-O
our	B-O
protein	B-O
anatomy	B-O
,	B-O
to	B-O
avoid	B-O
the	B-O
inclusion	B-O
of	B-O
variants	B-O
which	B-O
could	B-O
have	B-O
arisen	B-O
from	B-O
the	B-O
process	B-O
of	B-O
affinity	B-O
maturation.	B-O
For	B-O
all	B-O
calculations	B-O
of	B-O
enrichment	B-O
and	B-O
simulations	B-O
involving	B-O
protein	B-O
or	B-O
domain	B-O
“regions”	B-O
.	B-O
;	B-O
for	B-O
simplicity	B-O
and	B-O
consistency,	B-O
we	B-O
use	B-O
the	B-O
VES	B-AC
metric	B-O
for	B-O
variant	B-O
enrichment/depletion	B-O
within	B-O
a	B-O
given	B-O
entity	B-O
S2	B-O
Fig.	B-O
Comparison	B-O
of	B-O
VES	B-AC
and	B-O
density	B-O
metrics.	B-O
S4	B-O
Fig.	B-O
The	B-O
landscape	B-O
of	B-O
variant	B-O
enrichment	B-O
over	B-O
a	B-O
list	B-O
of	B-O
domain-types	B-O
most	B-O
enriched	B-O
in	B-O
pathogenic	B-O
and	B-O
population	B-O
variants.	B-O
of	B-O
pathway	B-O
enrichment	B-O
of	B-O
protein-wise	B-O
VES.	B-O
S7	B-O
Fig.	B-O
Spearman	B-O
correlations	B-O
for	B-O
missense	B-O
variant	B-O
enrichment,	B-O
protein	B-O
stability,	B-O
and	B-O
abundance.	B-O
S9	B-O
Fig.	B-O
The	B-O
Spearman	B-O
correlation	B-O
of	B-O
the	B-O
enrichment	B-O
of	B-O
missense	B-O
variants	B-O
with	B-O
protein	B-O
half-lives.	B-O
S11	B-O
Fig.	B-O
Functional	B-O
enrichment	B-O
of	B-O
proteins	B-O
in	B-O
KEGG	B-O
pathways	B-O
according	B-O
to	B-O
thermal	B-O
stability.	B-O
S13	B-O
Fig.	B-O
Functional	B-O
enrichment	B-O
of	B-O
proteins	B-O
in	B-O
KEGG	B-O
pathways	B-O
according	B-O
to	B-O
transcript	B-O
expression.	B-O
S15	B-O
Fig.	B-O
The	B-O
density	B-O
of	B-O
rare	B-O
mutations	B-O
from	B-O
the	B-O
gnomAD	B-O
data	B-O
in	B-O
different	B-O
protein	B-O
regions.	B-O
S17	B-O
Fig.	B-O
The	B-O
association	B-O
between	B-O
VES	B-AC
and	B-O
protein	B-O
stability	B-O
for	B-O
variants	B-O
scored	B-O
by	B-O
CADD	B-O
and	B-O
REVEL.	B-O
S19	B-O
Fig.	B-O
Pathway	B-O
enrichment	B-O
analysis	B-O
for	B-O
tolerable	B-O
and	B-O
damaging	B-O
variants	B-O
as	B-O
defined	B-O
by	B-O
CADD.	B-O
.	B-O
.	B-O
.	B-O
.	B-O
.	B-O
.	B-O
.	B-O
.	B-O
.	B-O
(ZIP)	B-O
S1	B-O
Appendix.	B-O
Detailed	B-O
description	B-O
of	B-O
data	B-O
files.	B-O
(PDF)	B-O
Acknowledgments	B-O
We	B-O
thank	B-O
Dr	B-O
Jens	B-O
Kleinjung	B-O
for	B-O
his	B-O
critical	B-O
reading	B-O
of	B-O
and	B-O
comments	B-O
on	B-O
this	B-O
manuscript,	B-O
and	B-O
members	B-O
of	B-O
the	B-O
Fraternali	B-O
group	B-O
for	B-O
valuable	B-O
discussion.	B-O
